6 Current news of Pfizer
rss08-12-2009
Researchers may be able to predict how people will respond to particular drugs by analysing their urine samples, suggest scientists behind a new study published in Proceedings of the National Academy of Sciences . Not all drugs are effective in all patients and occasionally, susceptible ...
04-20-2009
The club moss Lycopodium serratum is a creeping, flowerless plant used in homeopathic medicine to treat a wide variety of ailments. It contains a potent brew of alkaloids that have attracted considerable scientific and medical interest. However, the plant makes many of these compounds in ...
Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture
02-05-2007
Accelrys, Inc. announced the addition of Pfizer to the Accelrys Enterprise Cheminformatics Consortium. The Consortium will be a collaborative software development project led by Accelrys in partnership with a group of commercial member organizations. Its goal is to prioritize, design, and ...
01-11-2007
Archemix Corp. announced that it has signed an agreement with Pfizer focused on the discovery of first-in-class aptamers for the development and commercialization as therapeutics. As part of the collaboration, Archemix will use its proprietary SELEX technology to discover and generate product ...
New legislation threatens medicines
11-21-2006
Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ drugs - one of them an anticancer therapy - ...
07-25-2006
Tepnel Life Sciences PLC, a UK-based international Molecular Diagnostics and Research Products & Services group, announced that it's Scottish pharmaceutical services subsidiary, Tepnel Scientific Services Ltd, has entered into a quality agreement with Pfizer. Under the scope of this agreement ...
